|
|
|
|
LEADER |
01745nam a2200337 u 4500 |
001 |
EB001840031 |
003 |
EBX01000000000000001004020 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
180702 r ||| eng |
050 |
|
4 |
|a RC113.3
|
245 |
0 |
0 |
|a Point-of-care tests for infectious diseases
|h Elektronische Ressource
|b a review of clinical and cost-effectiveness and guidelines
|c prepared by Canadian Agency for Drugs and Technologies in Health
|
260 |
|
|
|a Ottawa, Ontario, Ottawa, Ontario
|b Canadian Agency for Drugs and Technology in Health, Canadian Electronic Library
|c 2016, 7 March 20162016
|
300 |
|
|
|a 1 PDF file (16 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references (pages 8-10)
|
653 |
|
|
|a Canada
|
653 |
|
|
|a Direct-To-Consumer Screening and Testing
|
653 |
|
|
|a Cost-Benefit Analysis
|
653 |
|
|
|a Communicable Diseases / diagnosis
|
653 |
|
|
|a Point-of-Care Systems
|
653 |
|
|
|a Guidelines as Topic
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a Rapid response report : summary with critical appraisal
|
500 |
|
|
|a "07 March 2016". - "CADTH Rapid Response Service."
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK355664
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 616.90475
|
082 |
0 |
|
|a 380
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a This report aims to review the clinical- and cost-effectiveness of over-the-counter POC testing of patient self-test or pharmacist testing for HIV, hepatitis C, influenza, and streptococcal infections. Guidelines associated with the use of POC testing for infectious diseases will also be examined
|